Home BIOTECHNOLOGY

BIOTECHNOLOGY

EB-Plate Is the First Completely Reusable 3D Cell Culture Microplate Launched by eNUVIO

EB-Plate comes to the market at the right time as the demand for 3D cell culture microplates is high, conventional plastic plates are currently in short supply, and the zero-waste movement is becoming increasingly popular in laboratories.

EKF Diagnostics Introduces One of the 1st tests to Precisely Measure Levels of COVID-19 Neutralizing Antibodies in Individuals

Unlike other antibody tests, the Kantaro COVID-SeroKlir SARS-CoV-2 IgG antibody test kit determines both the presence and specific quantities of human IgG antibodies to the SARS-CoV-2 virus.

Cold Spring Harbor Laboratory Scientists Develop the World’s 1st DNA “tricorder” In Your Pocket

December 7, 2020 Cold Spring Harbor Laboratory scientists developed the world's first mobile genome sequence analyzer, a new iPhone app called iGenomics. By pairing an iPhone with a handheld DNA sequencer, users can create a mobile genetics laboratory,...

New England Biolabs® Introduces NEBNext® Custom RNA Depletion Design Tool and RNA Depletion Core Reagent Set for Customizable RNA Depletion

This technology has been superb for eliminating the ribosomal RNA for a range of custom projects, including tracking novel viruses in mosquitoes, longitudinal profiling for astronauts, and host-pathogen interactions in COVID samples.

INTERCEPT Blood System for Cryoprecipitation Receives FDA Approval States Cerus Corporation

"FDA approval of the INTERCEPT Blood System for Cryoprecipitation is an important step forward in our mission to establish pathogen reduction as the standard of care for transfused blood components globally," said William ‘Obi’ Greenman, Cerus’ president and chief executive officer.

Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China

Led by the Wuxi municipal government and administered by the National Cancer Center in China, the “Liver Cancer Early Screening Comprehensive Prevention and Control Project” is a public health initiative.

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix notes the research paper has been submitted to a prestigious journal specializing in tissue regeneration for peer review and editing.

OrganaBio to Expand Its cGMP Cell and Gene Therapy Manufacturing Facility: 19,000 Sq. Ft. Slated to Commence Operations In Q3 2021

OrganBio, a Miami-based cGMP facility, will include process development space, ISO 7 cleanrooms, state-of-the-art scientific equipment, analytics and QC laboratories, and a suite of support services to enable OrganaBio and its partners to rapidly and economically self-manufacture clinical materials.